Lanreotide
Pharmaceutical drug / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Lanreotide?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
Lanreotide, sold under the brand name Somatuline among others, is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome. It is a long-acting analogue of somatostatin, like octreotide.
Quick Facts Clinical data, Trade names ...
Clinical data | |
---|---|
Trade names | Somatuline |
Other names | Lanreotide acetate (JAN JP), Lanreotide acetate (USAN US) |
AHFS/Drugs.com | Monograph |
License data |
|
Pregnancy category |
|
Routes of administration | Intramuscular, subcutaneous |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | Approximately 80% |
Protein binding | 78% |
Metabolism | In GI tract |
Elimination half-life | 2 hours (immediate release) 5 days (sustained release) |
Excretion | Mostly bile duct |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider |
|
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.215.992 |
Chemical and physical data | |
Formula | C54H69N11O10S2 |
Molar mass | 1096.33 g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) (verify) |
Close
Lanreotide (as lanreotide acetate) is manufactured by Ipsen. It is available in several countries, including the United Kingdom, Australia and Canada, and was approved for sale in the United States by the Food and Drug Administration (FDA) on August 30, 2007.[2]